Health
4.8
Hong Kong biomedical innovation faces commercialization hurdles despite research strength
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateSouth China Morning PostLow-rated sourceHK
Research on the 'immortal' jellyfish Turritopsis dohrnii, whose regenerative abilities were first documented in 1992, is being explored for potential applications in treating human diseases. The article highlights how understanding cellular rejuvenation could lead to medical breakthroughs, though specific therapeutic applications remain speculative.
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 11 h ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported